Literature DB >> 26410137

Drug-Induced Acute Kidney Injury: A Focus on Risk Assessment for Prevention.

Sandra L Kane-Gill1, Stuart L Goldstein2.   

Abstract

Drugs are the third to fifth leading cause of acute kidney injury (AKI) in critically ill patients following sepsis and hypotension. Susceptibilities and exposures for development of AKI have been identified, and some are modifiable allowing for the possibility of AKI prevention or mitigation of AKI severity. Using drug therapies for prevention of AKI has been attempted but with little success in human studies, so we must rely on risk-assessment strategies for prevention. The purpose of this article is to review the risk factors, risk-assessment strategies, prevention, and management of drug-induced AKI with emphasis on risk assessment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Drug-induced acute kidney injury; Drug-related side effects and adverse drug reactions; Prevention; Risk assessment; Risk factors

Mesh:

Year:  2015        PMID: 26410137     DOI: 10.1016/j.ccc.2015.06.005

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  19 in total

Review 1.  Drug-associated acute kidney injury: who's at risk?

Authors:  Emily L Joyce; Sandra L Kane-Gill; Dana Y Fuhrman; John A Kellum
Journal:  Pediatr Nephrol       Date:  2016-06-23       Impact factor: 3.714

2.  Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.

Authors:  Amanda M Uber; Maria E Montez-Rath; David M Kwiatkowski; Catherine D Krawczeski; Scott M Sutherland
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

3.  Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury.

Authors:  Amayelle Rey; Valérie Gras-Champel; Thibaut Balcaen; Gabriel Choukroun; Kamel Masmoudi; Sophie Liabeuf
Journal:  J Nephrol       Date:  2021-10-07       Impact factor: 3.902

4.  Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.

Authors:  Hossein Khalili; Hamid Rahmani; Mostafa Mohammadi; Mohamadreza Salehi; Zahra Mostafavi
Journal:  Daru       Date:  2021-08-31       Impact factor: 4.088

5.  Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases.

Authors:  Amayelle Rey; Valérie Gras; Julien Moragny; Gabriel Choukroun; Kamel Masmoudi; Sophie Liabeuf
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

6.  Acute kidney injury in a patient with gout and polyarticular septic arthritis: a case report.

Authors:  Jie Zhang; Min Yang; Xiaoyu Cheng; Fei Qin; Shizhe Zhou; Hui Guo; Youlin Fan; Yajie Wei; Lidan Ma; Tian Liu; Ruixia Sun; Ying Chen
Journal:  Int Urol Nephrol       Date:  2022-03-26       Impact factor: 2.266

7.  Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury.

Authors:  Robert A McKee; Rebecca A Wingert
Journal:  J Vis Exp       Date:  2016-07-17       Impact factor: 1.355

Review 8.  Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.

Authors:  Sandra L Kane-Gill; Pamela L Smithburger; Kianoush Kashani; John A Kellum; Erin Frazee
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

9.  Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.

Authors:  Marlies Ostermann; Lakhmir S Chawla; Lui G Forni; Sandra L Kane-Gill; John A Kellum; Jay Koyner; Patrick T Murray; Claudio Ronco; Stuart L Goldstein
Journal:  Br J Clin Pharmacol       Date:  2017-12-01       Impact factor: 4.335

10.  Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study.

Authors:  Sheng-Yuan Ruan; Hon-Yen Wu; Hsien-Ho Lin; Huey-Dong Wu; Chong-Jen Yu; Mei-Shu Lai
Journal:  Crit Care       Date:  2016-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.